Annelies Vellekoop
Papers
1
Total Citations
15
H-Index
1
About
Annelies Vellekoop is a leading researcher in nuclear medicine and oncology, with a primary focus on advancing molecular imaging for prostate cancer management. Her work centers on the clinical utility of PSMA-targeted PET/CT, particularly using 18F-DCFPyL, to improve disease characterization and guide treatment decisions. Her most cited study, a multicenter retrospective analysis published in 2021, demonstrated that PSMA PET/CT significantly altered management plans in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive therapy, highlighting its critical role in precision oncology. With 15 citations, this work underscores her impact on reshaping clinical paradigms for early, accurate disease detection. Vellekoop’s research bridges imaging innovation and patient-centered outcomes, offering clinicians actionable insights for tailoring therapies. Her contributions are pivotal for students and researchers exploring the intersection of radiopharmaceuticals and personalized cancer care, establishing her as a key voice in the evolving landscape of prostate cancer imaging.
Research Focus
Key Achievements
Top Papers
- 1